TCL Archive Advocacy Group Amasses Support For Bill That Threatens Integrity of NCI Peer Review August 3, 2012
TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014
TCL Archive ODAC Meeting: Further Restrictions Likely On ESA Use; Changes Advocated by ODAC May Cut Market By 40-50 Percent. March 21, 2008